Federated Hermes’s AN2 Therapeutics ANTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13K | Hold |
12,237
| – | – | ﹤0.01% | 1777 |
|
|
2025
Q1 | $16.6K | Buy |
12,237
+4,745
| +63% | +$6.45K | ﹤0.01% | 1754 |
|
|
2024
Q4 | $10.3K | Buy |
7,492
+4,486
| +149% | +$6.19K | ﹤0.01% | 1837 |
|
|
2024
Q3 | $3.22K | Buy |
3,006
+2,089
| +228% | +$2.24K | ﹤0.01% | 1901 |
|
|
2024
Q2 | $1.97K | Buy |
917
+706
| +335% | +$1.52K | ﹤0.01% | 1901 |
|
|
2024
Q1 | $686 | Sell |
211
-47
| -18% | -$153 | ﹤0.01% | 1976 |
|
|
2023
Q4 | $5.29K | Buy |
258
+160
| +163% | +$3.28K | ﹤0.01% | 1847 |
|
|
2023
Q3 | $1.58K | Buy |
+98
| New | +$1.58K | ﹤0.01% | 1986 |
|